What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes

Seminars in Perinatology

Volumn 27, Issue 3, 2003, Pages 217-230

  Mercer, Brian M ^a   Goldenberg, Robert L ^b   Das, Anita F ^c   Thurnau, Gary R ^d   Bendon, Robert W ^e   Miodovnik, Menachem ^f   Ramsey, Risa D ^g   Rabello, Yolanda A ^h  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d St John's Hospital   (United States)

^e KOSAIR CHILDREN'S HOSPITAL   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h White Memorial Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ERYTHROMYCIN; PLACEBO;

ADULT; AMNION FLUID; AMNIONITIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; FETUS LUNG MATURATION; GESTATIONAL AGE; HISTOLOGY; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN; NEWBORN MORBIDITY; OLIGOHYDRAMNIOS; PLACENTA; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037999040     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(03)00016-8     Document Type: Article

References (39)

1. Mercer BM, Goldenberg RL, Meis PJ, et al: The Preterm Prediction Study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 183:738-745, 2000
2. Mercer B: Antibiotic therapy for preterm premature rupture of membranes. Clin Obstet and Gynecol 41:461-468, 1998
3. Egarter C, Leitich H, Karas H, et al: Antibiotic treatment in premature rupture of membranes and neonatal morbidity: A meta-analysis. Am J Obstet Gynecol 174:589-597, 1996
4. Cox SM, Leveno KJ, Sherman ML, et al: Ruptured membranes at 24 to 29 weeks: A randomized double blind trial of antimicrobials versus placebo. Am J Obstet Gynecol 172:412, 1995
5. Ovalle-Salas A, Gomez R, Martinez MA, et al: Antibiotic therapy in patients with preterm premature rupture of membranes: A prospective, randomized, placebo-controlled study with microbiological assessment of the amniotic cavity and lower genital tract. Prenat Neonat Med 2:213-222, 1997
6. Svare J: Preterm delivery and subclinical uro-genital infection [thesis]. Denmark: Department of Obstetrics and Gynaecology Rigshospitalet, University of Copenhagen, 1997. Summarized in Kenyon S, Boulvain M (eds): Antibiotics for Preterm Premature Rupture of Membranes (Cochrane Review). The Cochrane Library, Issue 2, 2001, Oxford: Update software.
7. Svare J: Preterm delivery and subclinical uro-genital infection [thesis]. Denmark: Department of Obstetrics and Gynaecology Rigshospitalet, University of Copenhagen, 1997. Summarized in Kenyon S, Boulvain M (eds): Antibiotics for Preterm Premature Rupture of Membranes (Cochrane Review). The Cochrane Library, Issue 2, 2001, Oxford: Update software.
8. Mercer B, Moretti M, Rogers R, Sibai B: Antibiotic prophylaxis in preterm premature rupture of the membranes: A prospective randomized double-blind trial of 220 patients. Am J Obstet Gynecol 166:794-802, 1992
9. Amon E, Lewis SV, Sibai BM, et al: Ampicillin prophylaxis in preterm premature rupture of the membranes: A prospective randomized study. Am J Obstet Gynecol 159:539-543, 1988
10. Johnston MM, Sanchez-Ramos L, Vaughn AJ, et al: Antibiotic therapy in preterm premature rupture of the membranes: A randomized prospective double-blind trial. Am J Obstet Gynecol 163:743-747, 1990
11. McGregor JA, French JI, Seo K: Antimicrobial therapy in preterm premature rupture of membranes: Results of a prospective, double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol 165:632-640, 1991
12. Christmas JT, Cox SM, Andrews W, et al: Expectant management of preterm ruptured membranes: Effects of antimicrobial therapy. Obstet Gynecol 80:759-762, 1992
13. Lockwood CJ, Costigan K, Ghidini A, et al: Double-blind placebo-controlled trial of Piperacillin prophylaxis in preterm membrane rupture. Am J Obstet Gynecol 169:970-976, 1993
14. Morales WJ, Angel JL, OBrien WF, et al: Use of Ampicillin and corticosteroids in premature rupture of the membranes: A randomized study. Obstet Gynecol 73:721-726, 1989
15. National Institutes of Health Consensus Development Conference Statement: Effects of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994. Am J Obstet Gynecol 173:246-252, 1995
16. Mercer BM, Miodovnik M, Thurnau GR, et al: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 278:989-995, 1997
17. Schrag S, Gorwitz R, Fultz-Butts K, et al: Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51:1-22, 2002
18. Lewis DF, Brody K, Edwards MS, et al: Preterm premature ruptured membranes: A randomized trial of steroids after treatment with antibiotics. Obstet Gynecol 88:801-805, 1996
19. Harding JE, Pang J, Knight DB, et al: Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol 184:131-139, 2001
20. Beazley D: Impact of amnionitis and antepartum antibiotic treatment on neonatal outcome after pPROM. Am J Obstet Gynecol 178:S15(abstr) for the NICHD-MFMU Network, Bethesda, MD, 1998
21. Mercer B: Maternal and neonatal plasma cytokine levels and perinatal morbidity after preterm PROM. J Soc Gynecol Investig 4:154A(abstr, suppl) for the NICHD MFMU Network, Bethesda, MD, 1997
22. Mercer B: Maternal and neonatal circulating ICAM-1 for the prediction of perinatal morbidity after preterm PROM. J Soc Gynecol Investig 4:153A(abstr, suppl) for the NICHD MFMU Network, Bethesda, MD, 1997
23. Tamura T, Goldenberg RL, Johnston KE, et al: Serum ferritin: A predictor of early spontaneous preterm delivery. Obstet Gynecol 87:360-365, 1996
24. Goldenberg RL, Tamura T, DuBard M, et al: Plasma ferritin and pregnancy outcome. Am J Obstet Gynecol 175:1356-1359, 1996
25. Goldenberg RL, Mercer BM, Miodovnik M, et al: Plasma ferritin, premature rupture of membranes, and pregnancy outcome. Am J Obstet Gynecol 179:1599-1604, 1998
26. Wu YW, Colford JM Jr: Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis JAMA 20:284:1417-1424, 2001
27. Yoon BH, Jun JK, Romero R, et al: Amniotic fluid inflammatory cytokines (interleukin-6, interleukin 1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 177:19-26, 1997
28. Yoon BH, Romero R, Kim CJ, et al: High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 177:406-411, 1997
29. Yoon BH, Romero R, Yang SH, et al: Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174:1433-1440, 1996
30. Hauth JC: The NICHD-MFMU Antibiotic treatment of pPROM study: Correlation with acute placental inflammation and perinatal morbidity. Am J Obstet Gynecol 176:S53(abstr), 1997
31. Bendon RW, Faye-Petersen O, Pavlova Z, et al: Histologic features of chorioamnion membrane rupture: Development of methodology. Pediatr Pathol Lab Med 17:27-42, 1997
32. Bendon RW, Faye-Petersen O, Pavlova Z, et al: Fetal membrane histology in preterm premature rupture of membranes: Comparison to controls, and between antibiotic and placebo treatment. Pediatr Dev Pathol 2:552-558, 1999
33. Mercer BM: The NICHD-MFMU Antibiotic treatment of pPROM study: Multivariate analysis of factors associated with successful outcome after expectant management of pPROM. Am J Obstet Gynecol 176:S8(abstr) for the NICHD-MFMU Network, 1997
34. Hnat M: Preterm rupture of membranes at 24-32 weeks: Recent vaginal bleeding and perinatal outcome. Am J Obstet Gynecol 186:S142(abstr) for the NICHD-MFMU Network, Bethesda, MD, 2002
35. Thurnau G: The NICHD-MFMU antibiotic treatment of pPROM study: Impact of initial amniotic fluid volume on pregnancy outcome. Am J Obstet Gynecol 176:S53(abstr) for the NICHD-MFMU Network, Bethesda, MD, 1997
36. Alexander JM, Mercer BM, Miodovnik M, et al: The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol 183:1003-1007, 2000
37. Mercer BM: Accuracy of ultrasound for prediction of birthweight after pPROM. Am J Obstet Gynecol 178:S198(abstr) for the NICHD-MFMU Network, Bethesda, MD, 1997
38. How H: The accuracy of vaginal pool fetal pulmonary maturity testing at gestational ages of less than 31 weeks. Am J Obstet Gynecol 178:S185(abstr) for the NICHD-MFMU Network, Bethesda, MD, 1998
39. Kenyon SL, Taylor DJ, Tarnow-Mordi W: Oracle Collaborative Group. Broad spectrum antibiotics for preterm, prelabor rupture of fetal membranes: The ORACLE I Randomized trial. Lancet 357:979-988, 2001